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Abstract
Background: Macrophages are highly specialized immune cells of different developmental origin, which occur in
a continuum of diverse functional states in almost all tissues. In order to fulfil their complex role in tissue
homeostasis and defence against pathogens they must be able to live with heterogeneous extrinsic nutrient
conditions in tissue niches and handle variation in intrinsic metabolic demand that is determined by differentiation
state, functional specialization and immune challenge. The purpose of the present study was to gain more insight in
how metabolic specialization and versatility in fate and immune effector function of macrophages are coupled.
Methods: In vitro phenotypic characteristics of two macrophage cell lineages of profoundly different
developmental origin and polarization capacity, RAW 264.7 and Maf-DKO cells, were analysed. By use of
biochemical and cell biological approaches and scanning electron microscopy, we studied the metabolic profiles of
these two types of macrophages in relation to proliferative capacity, morphological appearance of cell surface and
cell shape, and phagocytic activity as index of morphodynamic potential.
Results: Comparison of gross features of carbohydrate metabolism, including levels of glycolytic enzymes
Hexokinase (HK), Pyruvate Kinase (PK-M2), lactate dehydrogenase and nicotinamide phosphoribosyltransferase
(Nampt), glucose and oxygen consumption and lactate production rates, and intracellular concentrations and redox
ratios of NAD(P)(H) demonstrated that RAW 264.7 and Maf-DKO cells are conspicuously similar in that they both
rely heavily on the use of glycolysis. In this respect they share many characteristics with primary macrophages.
Strikingly, this uniform metabolic signature does not translate in behavioral-functional similarities as RAW 264.7 cells
have a significantly higher proliferation rate, whereas Maf-DKO cells appear to be morphodynamically more active,
form significantly more surface membrane protrusions and phagocytose complement opsonized particles much
more efficiently.
Conclusion: We conclude that the global rate of glycolysis in intermediary carbohydrate metabolism is similar for
the two cell lineages, but that they can make differential use of this important pathway, either to fuel high
morphodynamic activity in Maf-DKO cells, or for the sustenance of cell growth in fast proliferating RAW 264.7 cells.
Our findings are in keeping with the idea that macrophages may uniformly prefer use of the rapid response time of
glycolysis because this pathway provides them with the ability to meet any possible short-timescale energy demand
required for immune function.
Keywords: Macrophages; Phagocytosis; Glycolysis; Carbohydrate
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Introduction
Macrophages are highly versatile immune cells that provide a first
line of defence against pathogens and help to maintain tissue
homeostasis by eliminating foreign matter and apoptotic cells via
phagocytosis and secreting cytokines and growth factors. They are
present throughout the vertebrate body in almost all tissues, including
tumors, where they can undergo region-specific differentiation [1-3].
Although all types of macrophages were originally collectively
classified under the Mononuclear Phagocyte System (MPS) [4], we
now know that they are in fact rather heterogeneous populations of
cells, which develop from common Haematopoietic Stem Cells (HSCs)
in the bone marrow or from embryonic progenitors that are already
prenatally established in various tissues [5,6].
Macrophages constantly survey their environment for signs of
tissue injury, dying cells, toxic materials, or invading organisms [1].
When they encounter foreign material (e.g. bacterial products) or are
exposed to stimuli like inflammatory cytokines (IFN-γ, TNF, or
interleukins) and Immunoglobulin G (IgG) immune complexes they
gain specific functional properties and become specialized polarized
cells [7], known as classically activated (M1), alternatively activated
(M2 or M2a) or regulatory macrophages (M2b&c) [8-10]. After
differentiation, macrophages retain plasticity and further adapt their
functional phenotype in response to micro environmental cues [11],
resulting in a continuum of diverse functional states [7].
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Until recently, not many workers in the field of immunology paid
attention to the metabolic routes and needs of specialist macrophages.
Previous studies performed on mixtures of cells with different origins
and activation/polarization status, like Thioglycollate-Elicited Mouse
Peritoneal Macrophages (TEPMs) with a M2-like phenotype [12,13],
resident peritoneal macrophages [14], or blood monocytes during
differentiation [15] in vitro [16] under different conditions [17,18],
have reported that all macrophages, irrespective of origin, tissue type,
or oxygenation levels, exhibit a high rate of glycolysis. In activated
macrophages up to 95% of all glucose consumed can be converted to
lactate [15] instead of being oxidized via the TCA-cycle and OXPHOS,
even under aerobic conditions. In this regard, macrophage metabolism
closely resembles the “Warburg phenotype” of cancer cells [19,20].
New work has now revealed that this metabolic signature is not
static and that differentiation and specialization can strongly influence
macrophage metabolism [21]. Also the reciprocal relationship, i.e. that
metabolism determines differentiation state may be true [22]. Upon
polarization, carbohydrate catabolism is thus thought as being tuned
to meet the specific requirements for performing different effector
functions such as phagocytosis, cytokine secretion, ROS production,
and ECM synthesis [21].
Unfortunately, detailed monitoring of this metabolic versatility in
the in vivo situation is still not feasible, because natural macrophage
populations are heterogeneous and display multiple stages of
functional activation while stationary residing in their own (micro)
environment or dynamically traversing tissue regions under different
oxygenation and nutrient supply conditions. Moreover, metabolic
studies on single cells are currently virtually impossible. The best
approach for analysis and interpretation of metabolic data is therefore
in vivo study of large populations of macrophages. Although relatively
pure collections of primary murine macrophages can be obtained
fairly easily from the peritoneal cavity, the lungs, or the bone marrow
[23], these macrophages, like most mature differentiated cells, are
difficult to manipulate and can be maintained in culture for only a few
days [24]. Use of immortal clonally-derived macrophage cell lineages,
such as the murine J744.A or RAW 264.7 monocyte/macrophage cell
lines or human THP-1 cells offers an often used alternative route,
however, here a caveat is that all these models have a cancerous
background (i.e. originate from reticulum cell sarcoma/plasmacytoma,
Abelson MLV-induced ascites or monocytic leukaemia progenitors)
and possess abnormal differentiation potential [25,26]. Although there
is no doubt that these macrophage lineages share many properties with
primary macrophages, one must keep in mind that they also share the
hallmarks of true cancer cells.
For a better understanding of metabolic versatility of macrophages
comparative study of oncogenically transformed and non-transformed
lineages is therefore warranted. Here we report on the parallel analysis
of RAW 264.7 cells, the most intensely studied mammalian
macrophage lineage, and Maf-DKO (DKO=Double Knockout) cells, a
relatively novel lineage that was recently derived from mice with a
MafB/c-Maf deficient hematopoietic system [27]. In the presence of
M-CSF, these Maf-DKO monocytic cells proliferate and differentiate
into macrophages, which can be expanded in culture without losing
their differentiated phenotype. In contrast to RAW 264.7 cells, Maf-
DKO cells do not have a cancerous background, show normal homing
and functional integration into macrophage populations of tissues and
do not themselves produce tumors when transplanted back in vivo,
into mice [27]. Despite the lack of MafB and c-Maf transcription
factors, this cell model is positive for specific monocyte/macrophage
surface markers, and is surprisingly similar to primary macrophages
with regard to gene expression profile, morphology, and phagocytic
capacity [27].
We report that RAW 264.7 cells have a markedly increased
proliferation rate compared to Maf-DKO cells, both in presence and
absence of M-CSF. Moreover, these two macrophage cell lineages also
have dramatically different morphological appearance before and after
polarization and also have different phagocytosis capacity.
Conspicuously, their metabolic signatures showed no dramatic
differences. Both cell lineages are similarly glycolytic, with comparable
responses to metabolic inhibitors, although slight differences in
intracellular concentrations of NAD(H)/NADP(H) and expression
levels of some glycolytic and NAD+-synthesis enzymes do occur. Our
findings provide the first indication that metabolic profiles of different
types of macrophages may show remarkable phenotypic identity, while
proliferative and immune capacity may vary widely.
Materials and Methods
Reagents
All reagents were obtained from Sigma-Aldrich (St. Louis, MO,
USA), unless stated otherwise.
Cell culture
RAW 264.7 cells (kind gift from Dr. Hong-Hee Kim, Department of
Cell and Developmental Biology, School of Dentistry, Seoul National
University, Korea [28]) were maintained in high-glucose DMEM
(Gibco, Life Technologies, Paisley, UK) supplemented with 10% heat
inactivated FBS (PAA laboratories, Pasching, Austria), 1 mM sodium
pyruvate, and 4 mM GlutaMAX (Gibco, Life Technologies, Paisley,
UK), at 37°C in a humidified atmosphere with 7.5% CO2. Maf-DKO
cells (kind gift from Dr. Michael H. Sieweke, Centre d’Immunologie
de Marseille-Luminy (CIML), Université Aix-Marseille, France [27])
were maintained in the same way except that medium was
supplemented with 20% Conditioned Medium (CM) from
Macrophage Colony Stimulating Factor (M-CSF)-producing L929-
cells [29].
Proliferation assay
Cell proliferation was analyzed by sulforhodamine B (SRB) staining
of protein content according to the protocol developed by Skehan et al.
[30]. To compare proliferation in the presence and absence of M-CSF,
RAW 264.7 and Maf-DKO cells were seeded in three 96-well plates
(25,000 cells/well) in 100 µl culture medium with or without 20%
L929-cell CM and incubated at 37°C. After 6 (T0), 21 (T15), and 30
(T24) hours the plates were washed twice with cold PBS and fixed with
10% trichloroacetic acid (TCA; J.T.Baker, Deventer, Holland) for 1
hour at 4°C. After fixation, plates were washed five times with water
and stored at -20°C until all plates were collected. Cellular protein was
stained with 50 µl 0.5% SRB in 1% acetic acid for 20 minutes after
which wells were washed four times with 1% acetic acid. Plates were
dried at 60°C for 3 hours, protein was dissolved in 150 µl 10 mM Tris-
HCl (pH 10.5), and the absorbance of each well was measured at 510
nm on a BioRad Benchmark Plus micro plate reader. Values were
corrected for background SRB staining by subtracting the average
absorbance value of wells that contained medium only, from that of
wells with cells. To determine the effect of 2-DG and oligomycin on
proliferation, RAW 264.7 and Maf-DKO cells were seeded in three 96
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well plates at a density of 7,500 and 25,000 cells/well, respectively.
RAW 264.7 cells were incubated for 6 hours and Maf-DKO cells
overnight before wells were washed once with medium containing
either 10 mM 2-deoxy-D-glucose (2-DG) or 2.5 µM oligomycin and
cells were incubated in the same medium for 24, 48 or 72 hours. Cells
were then fixed and stained as described above.
Western blot analysis
Protein expression was analysed by western blot analysis. After
washing cells twice with cold PBS in 6 cm culture dishes, cell lysates
were prepared in lysis buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl,
5 mM MgCl2, and 0.5% NP-40; 4°C) and stored at -20°C until analysis.
Lysates containing ± 10 µg protein were mixed with 5x sample buffer
(0.25 % Bromophenol Blue, 0.5 M DTT, 50 ml glycerol, 10 %SDS, and
0.25 M Tris-HCl pH 6.8), heated at 95°C for 5 minutes, and loaded
onto 10 or 12% SDS-PAGE gels, depending on the size of the protein
of interest. After electrophoretic separation, proteins were blotted onto
PVDF membranes. Membranes were blocked with 5% (w/v) skimmed
milk in PBS-T (HXK1, HXK2, LDH-A, actin and NAMPT) or TBS-T
(PKM2 and NAPRT) for 1 hour and labelled overnight with a mouse
anti-Tubulin (1:5000; DSHB, University of Iowa) and either a goat
anti-HXK1 (1:200; Santa Cruz Biotechnology), goat anti-HXK2 (1:200;
Santa Cruz Biotechnology), goat anti-LDH-A (1:5000; Cell Signalling
Technology), rabbit anti-PKM2 (1:1000; Cell Signalling Technology),
rabbit anti-actin (1:1000; Cytoskeleton Inc.), rabbit anti-NAMPT
(1:2500; Behthyl Laboratories, Montgomery, TX, USA) or anti-
NAPRT (1:1000; Sigma-Aldrich, St. Louis, MO, USA) antibodies at
4°C. After washing the membranes three times for 5 minutes with
PBS-T or TBS-T, they were incubated with IR Dye secondary
antibodies (donkey anti-goat 680, goat anti-rabbit 680, goat anti-rabbit
800, goat anti-mouse 680, and/or goat anti-mouse 800) for one hour at
room temperature. This was followed by 4 wash steps of 5 minutes
each in PBS-T or TBS-T, a final wash step in PBS, and signal detection
on the Odyssey Infrared Imaging System (LI-COR Biosciences,
Lincoln, NE, USA). Tubulin served as loading control and reference
for calculation of protein content.
Glucose and lactate measurements
Glucose consumption measurements were based on the Amplex
Red Glucose/Glucose Oxidase assay kit from Molecular probes (Life
Technologies, Eugene, Oregon, USA). Glucose, glucose oxidase, and
Amplex Red reagent were used from the kit but horseradish
peroxidase was obtained from Sigma-Aldrich (St. Louis, MO, USA)
and 1x reaction buffer was replaced with 0.05 M Tris-HCl, pH 7.5.
Apart from these minor changes, the kit protocol was followed as
described by the manufacturer. Lactate production was measured
using the same protocol as for glucose consumption but replacing
glucose oxidase with lactate oxidase and including a lactate standard
series instead of glucose. Cells were seeded in 12 well tissue culture
plates in medium containing 20% L929-cell CM and incubated
overnight. For glucose measurements, medium containing 5 mM
glucose was used while lactate production was measured for cells
grown in 25 mM glucose medium. The next day, wells were rinsed
with pure DMEM containing no glucose and fresh control medium
(containing 10% heat inactivated dialyzed FBS, 1 mM sodium
pyruvate, and 4 mM GlutaMAX) or medium containing 2.5 µM
oligomycin was added. After 6 hours, medium was collected and
supernatants were snap frozen in liquid nitrogen and stored at -20°C
until analysis. Cytosolic extracts were prepared in lysis buffer (50 mM
Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2, and 0.5% NP-40; 4°C)
and total protein was determined with the Bradford assay. Glucose
consumption was calculated by subtracting the amount of glucose in
the sample from that in medium without cells. Lactate production was
calculated by subtracting the concentration of any lactate in the
medium without cells from that of the samples. Glucose and lactate
assays were performed in parallel.
LDH-isoenzyme expression
LDH-isoenzymes were separated using the SAS-MX LDH
Isoenzyme gel electrophoresis test from Helena Biosciences Europe,
according to the manufacturer’s specifications. Cell lysates were
prepared as for western blot and protein concentration was
determined with the Bradford assay. Per lane, approximately 2.8 µg of
protein was loaded.
NAD(H)/NADP(H) measurements
Intracellular NAD+, NADH, NADP+, NADPH concentrations were
measured exactly as described [31].
Oxygen consumption measurements
An Oroboros Oxygraph-2k respirometer was used to measure
oxygen consumption in RAW 264.7 and Maf-DKO cells according to a
standard protocol provided by the manufacturer. RAW 264.7 cells
were incubated in medium with 20% L929-cell CM for at least 24
hours prior to assay. The two cell lines were analysed in parallel in two
separate chambers of the respirometer. After air calibration of the
medium in the chambers and stabilization of the signal, 1 x 106 cells
(in 60 µl medium) were injected into the respective chambers. Basal
respiration rate was measured at the point where the O2-flux signal
stabilized. Oligomycin (2.5 µM) was added to each chamber and the
leak respiration rate was determined after stabilization of the signal.
Next, 7 µM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
(FCCP, a mitochondrial uncoupler) was added to reach maximal
oxygen consumption in the cells. Finally, 30 nM rotenone was added
and after stabilization of the system, the residual oxygen consumption
could be determined. The data was analysed using the DatLab software
provided with the instrument.
Scanning electron microscopy
RAW 264.7 and Maf-DKO cells were seeded on 12 mm glass
coverslips in 24-well plates in medium with or without L929-cell CM
and activated with 100 ng/ml LPS or left non-activated. Cells were
washed once with PBS and fixed with 2% glutarealdehyde in 0.1 M
sodium cacodylate buffer for 1 hour. After washing cells twice with
sodium cacodylate buffer, coverslips were stored in the same buffer at
4°C until further fixation with 1% OsO4 (osmium tetroxide) for 30
minutes. Coverslips were then washed once with water and dehydrated
in a graded series of alcohol, critical point dried, and mounted for
scanning electron microscopy (JEOL SEM6340F Field Emission
Scanning Electron microscope). Images were acquired at 500x as well
as a 2000x magnification.
Quantification of surface membrane protrusions
Dorsal surface protrusions were quantified using SEM-images. A
region of interest with an area of 20-130 µm2 was drawn on the cell
body of single cells using Fiji imaging software. All protrusive
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structures within this region were counted and the number of surface
protrusions per square micron was calculated. RAW 264.7 (n=17) and
Maf-DKO (n=25) cells from five different fields were analysed.
Cellular actin staining
RAW 264.7 and Maf-DKO cells were seeded on 12 mm glass
coverslips in 24-well plates in medium with or without L929-cell CM
and activated with 100 ng/ml LPS or left non-activated. Cells were
washed twice with PBS and fixed in 2% paraformaldehyde in 0.2 M
sodium phosphate buffer for 30 minutes. After washing twice with
PBS and twice with PBS containing 20 mM glycine (MP Biomedicals,
Illkirch Cedex, France; PBS-G) cells were permeabilized with 0.1%
saponine/PBS-G for 20 minutes. This was followed by actin staining
with Alexa 568-labeled phalloidin (1:600 in 0.1% saponine/PBS-G) for
1 hour. Cells were successively washed four times for 2-4 minutes with
0.1% saponine/PBS-G and once with PBS alone. Coverslips were
removed from wells, rinsed once in water, air dried, and embedded in
MoWiol on microscope slides. Images were acquired on a Zeiss
LSM510 META confocal laser scanning microscope using a 63x
objective and processed using Fiji imaging software.
Phagocytosis assay
Phagocytic activity was determined as zymosan ingestion capacity
essentially as described by Chang, et al. [28]. Zymosan particles were
dissolved in PBS at 10 mg/ml and left to rehydrate for at least one
hour. Next, zymosan was sonicated three times for 5 seconds, spun
down, resuspended in carbonate buffer (pH 9.6), sonicated, and
incubated with 1 µg/ml Fluorescein Isothiocyanate (FITC) for 1 hour
at room temperature, in the dark. After FITC labeling, zymosan was
washed three times with carbonate buffer and incubated in 1 M Tris-
HCl, pH 8.0, for 30 minutes. Zymosan was then washed twice with
PBS and finally resuspended in PBS. After one more sonication step,
FITC-labeled zymosan was divided in aliquots, frozen in liquid
nitrogen, and stored at -20°C.
For phagocytosis assays without M-CSF, 100,000 RAW 264.7 cells
were seeded per well in normal culture medium and 200,000 Maf-
DKO cells per well in medium with 20% L929-cell CM. For assays with
M-CSF, both RAW 264.7 and Maf-DKO cells were seeded in medium
containing L929-cell CM at a density of 75,000 and 200,000 cells per
well, respectively. Where applicable, cells were pre-incubated in
medium containing 2.5 µM oligomycin (0 or 24 hours) or 10 mM 2-
DG (3 hours) and activated overnight with 100 ng/ml LPS. FITC-
labelled zymosan particles were complement opsonized by incubation
in foetal bovine serum for 1 hour at 37°C, washed twice with PBS, and
finally resuspended in serum-free medium with or without L929-cell
CM and, where applicable, with or without oligomycin and 2-DG.
Cells were washed once with serum-free medium and incubated with 1
ml zymosan suspension for 30 minutes at 37°C. The particle-to-cell
ratio was approximately 10:1. Particle engulfment was terminated by
washing cells twice with PBS and removing extracellular zymosan by
treatment with 500 µl 100 U/ml lyticase for 10 minutes at room
temperature. Successively, cells were detached with 0.05% trypsin/0.5
mM EDTA (Gibco, Life Technologies, Paisley, UK), resuspended in 1
ml medium with serum, pelleted, and finally resuspended in 200 µl 1%
paraformaldehyde in PBS. Samples were analyzed by FACS and
phagocytosis efficiency was determined by measuring the fluorescence
intensity of the FITC positive population as well as the percentage of
cells in that population. The phagocytic index of each sample was
calculated as the product of the mean FITC intensity of the positive
population times the % of FITC positive cells.
Statistical analysis
Data was analyzed either with the Student’s t-test or using a two-
way ANOVA and the Bonferroni post-test (GraphPad software, Inc.,
Version 4). Values are expressed as mean ± SEM. Values were
considered to be significantly different when p values were < 0.05.
Results and Discussion
RAW 264.7 and Maf-DKO proliferation in the presence of
M-CSF
Cell proliferation is essential for innate immunity, required for
development and maintenance of tissue resident macrophages [6]. To
better compare the potential coupling between metabolic phenotype
and proliferative capacity of RAW 264.7 and Maf-DKO cells in
culture, we analysed first the effects of absence or presence of M-CSF
(in conditioned medium from L929 cells) on cell proliferation. In vivo,
M-CSF after being secreted by various cells [32,33], is found in the
circulation [34], from where it stimulates proliferation via activation of
cell cycle genes. M-CSF is also a known modulator of metabolic
activities [35]. Of note, MafB/c-Maf deficient (Maf-DKO) monocytes
require macrophage colony stimulating factor (M-CSF or CSF-1) for
their in vitro differentiation into M2-macrophages [27]. For RAW
264.7 cells to achieve differentiation in vitro, continuous presence of
M-CSF is no prerequisite, although they do require additional
stimulus to obtain either an M1 or M2 polarization state.
Figure1: Proliferation rates of RAW 264.7 and Maf-DKO cells in
the presence and absence of M-CSF. The SRB assay for total cell
protein mass was used to follow proliferation of RAW 264.7 and
Maf-DKO cells in the presence and absence of L929-cell CM (M-
CSF). The increase in cell mass is plotted as the change in optical
density at 510nm. Data represent means ± SEM of three
independent experiments performed in triplicate. (*p<0.05,
**p<0.01; unpaired t-test)
Under standard medium conditions (DMEM supplemented with
FBS, pyruvate and GlutaMax but without M-CSF) RAW 264.7 cells
had a significantly higher proliferation rate (Figure 1). In the presence
of M-CSF, added as 20% Conditioned Medium (CM), RAW 264.7
proliferation was further increased. Maf-DKO cells, on the other hand,
failed to divide without M-CSF but even in the presence of M-CSF
Maf-DKO cells had a significantly slower growth rate compared to
RAW 264.7. The high rate of traverse through cell cycle and the
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independence of RAW 264.7 proliferation on M-CSF most likely
reflect the malignant background of these cells. Conversely, the
considerable slower cycle time of Maf-DKO cells and the fact that M-
CSF is obligatory for their survival, confirms that these cells still have
retained features that are typical for primary macrophages. Whether
the double loss of MafB and c-Maf transcription factors also attributed
to the growth properties of Maf-DKO cells in vitro is not known, but
apparently this has had no large effect on their responsiveness to M-
CSF (see also Martinez et al. [35]).
Glycolytic and mitochondrial metabolism
For most cell types , especially tumor cells, proliferative capacity is
tightly coupled to glucose metabolism, whereby rapid cell division is
usually accompanied by an adaptive shift in metabolism to aerobic
glycolysis [19]. Macrophages could, however, be special in that even in
the untransformed state they appear highly glycolytic [36,37]. In order
to determine and compare the extent to which cancerous RAW 264.7
and normal Maf-DKO cells depend on glycolysis or mitochondrial
oxidative phosphorylation (OXPHOS), we assessed proliferation in the
presence and absence of the glycolysis inhibitor 2-deoxy-D-glucose (2-
DG) and the OXPHOS inhibitor oligomycin. In both cell lines glucose
metabolism via glycolysis appeared to be the primary pathway to fuel
proliferation. In the presence of 2-DG, proliferation ceased within 24
hours (Figures 2A and 2B). In contrast, in the presence of oligomycin,
both cell lines continued to proliferate for at least 72 hours, although
their growth rate was significantly reduced (Figures 2A and 2B). These
results confirm that RAW 264.7 and Maf-DKO cells – in accordance
with their monocyte-macrophage character - are both highly glycolytic
but that mitochondrial OXPHOS capacity in both cell lineages must be
intact, and used, to attain maximal growth rates.
Figure 2: Proliferation of RAW 264.7 and Maf-DKO cells in the
presence of glycolysis inhibitor 2-DG and OXPHOS inhibitor
oligomycin. RAW 264.7 (A) and Maf-DKO (B) cells were incubated
in control medium or medium containing 10mM 2-DG or 2.5 µM
oligomycin for 24, 48, or 72 hours, after which protein content was
determined with the SRB assay as described in the legend of Figure
1, and in M&M. In order to enable comparison of proliferation
rates, absorbance values were normalized to the control values at 24
hours, since RAW 264.7 and Maf-DKO cells were not seeded at
equal densities and absorbance values at 24 hours varied between
cell lines. Data represent means ± SEM of three independent
experiments performed in triplicate. (**p < 0.01, ***p < 0.001, Two-
way ANOVA and Bonferroni posttest)
To compare aspects of intermediary metabolism of RAW 264.7 and
Maf-DKO cells more closely, we next measured glucose consumption
and lactate production, compared the expression of certain glycolytic
enzymes, and determined mitochondrial respiration. Glucose
consumption and lactate production were measured relative to the
amount of protein per well. No significant differences were found in
the amount of glucose consumed (Figure 3A) and, although Maf-DKO
cells tended to produce less lactate (Figure 3B), both cell lines showed
a high glycolytic flux to lactate, with RAW 264.7 cells converting 75%
and Maf-DKO cells converting 70% of all glucose to lactate (ratio of
control bars, Figures 3A and 3B).
Figure 3: RAW 264.7 and Maf-DKO cells are highly glycolytic.
Glucose consumption (A) and lactate production (B) in RAW 264.7
and Maf-DKO cells in the presence and absence of the OXPHOS
inhibitor oligomycin. (C) Expression levels of four metabolic
enzymes that were noticeably different between the two cell lines.
Protein expression (relative to tubulin) was calculated from the
band intensities of three different blots and normalized to the
expression in RAW 264.7 (n=3 different assays). D, Zymogram
analysis of LDH-isoenzyme expression in RAW 264.7 and Maf-
DKO cells. To verify the gel’s capacity to separate LDH1-LDH5
isoforms of mouse and human origin, a lysate of the human glioma
cell line U87 (which expresses all five isoforms) was run in parallel
as a control (according to Eyben et al. [58]). Note the presence of
low levels of the LDH3 and LDH4 tetramers, containing two or one
H-subunits from the LDH-B gene in the Maf-DKO lysate. E,
Mitochondrial respiration measured as the basal oxygen
consumption (Basal), the leak respiration (Leak), maximal oxygen
consumption (Max), and residual oxygen consumption (Res). Data
in (C) represent band intensities of HXK I, HXK II, LDH-A, and
PKM2 of one blot, relative to tubulin. Data in A and B represent
means ± SEM of three independent experiments performed in
triplicate, and in E means ± SEM of four experiments performed
with RAW 264.7 and Maf-DKO cells in parallel.
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This percentage is lower than what was reported for quiescent
peritoneal macrophages in an earlier study by Rodríguez-Prados et al.
[15] where these cells converted 95% of all glucose to lactate. In the
same study RAW 264.7 were shown to have a glucose-lactate-
conversion of 80%, but to have an increased glycolytic flux rate (i.e.
consume and produce more glucose and lactate, respectively). Maf-
DKO cells, therefore, seem to have a glycolytic flux and flux rate more
comparable to RAW 264.7 cells than to quiescent peritoneal
macrophages under the culture conditions that we used in our
analyses. In both cell lines glucose consumption and lactate
production was marginally increased when mitochondrial OXPHOS
was inhibited with oligomycin.
Glycolytic enzymes are often differentially regulated in cancer cells
[38]. When the expression levels of some glycolytic enzymes of Raw
264.7 and Maf-DKO cells were compared on western blot, we did not
observe any overt differences. We did, however, notice that the
expression levels of lactate dehydrogenase (as verified by the level of
the A subunit; LDH-A), and pyruvate kinase M2 (PKM2) tended to be
slightly higher in RAW 264.7 cells, while the opposite was true for
HXK I (Figure 3C). Again, the profiles for enzyme expression are
indicative for sustenance of a high glycolytic rate, reminiscent of the
metabolic signatures of true cancer cells. It is particularly noteworthy
that both types of macrophages do express PKM2 (Figure 3C), the
special PKM splice isoform which has a pivotal role in tuning of
glycolytic rate and also use of associated biosynthetic pathways for the
generation of nucleotides (i.e. via the PPPathway) and lipids in fast
proliferating cells [39].
For LDH, the enzyme that catalyses the conversion of pyruvate to
lactate we performed a subunit composition analysis in addition to the
quantification of the main subunit, LDH-A (western blot, Figure 3C).
Lactate dehydrogenase may exist in five different isoforms (LDH1-5)
that differ from one another with regard to the ratio of the A and B
subunits in the tetramer and the capacity for pyruvate to lactate
conversion under physiological conditions. Zymogram analysis
showed that Maf-DKO cells, in contrast to RAW 264.7 cells, express
low amounts of LDH-B that enables the production of LDH3 and
LDH4. Still, zymogram intensities revealed no other overt differences.
As LDH5 activity staining appeared equally strong and this isoform
was by far most dominantly expressed in both cell types (Figure 3D)
we conclude that the available capacity for pyruvate and lactate
interconversion does not noticeably differ between the two
macrophage lineages.
When pyruvate is not converted to lactate it is transported across
the mitochondrial membrane and catabolized via the TCA-cycle and
used to produce ATP via OXPHOS. In order to compare the
mitochondrial activity of RAW 264.7 and Maf-DKO cells, we
measured oxygen consumption in absence and presence of certain
OXPHOS inhibitors in order to determine basal O2-consumption as
well as the amount of oxygen that is consumed without producing
ATP (leak), the respiration capacity (maximal respiration rate), and
the amount of oxygen consumption by systems other than the electron
transport chain (residual oxygen consumption), for example NADPH
oxidases [40]. Both cell lines exhibited a relatively low O2-
consumption (~ 20 pmol.s-1.10-6 cells compared to ~ 100 pmol.s-1.10-6
cells for mouse embryonic fibroblasts [41]; Figure 3E). Indeed, if only
a minor fraction of glucose-derived pyruvate enters the TCA cycle and
ultimately serves to fuel OXPHOS, this may explain why treatment
with oligomycin did not significantly alter the glycolytic flux (Figures
3A and 3B). Of note, no differences were detected in basal oxygen
consumption between RAW 264.7 and Maf-DKO, neither did the cell
lines differ in leak, maximal, or residual O2-consumption (Figure 3E).
Intracellular NAD (H) and NADP(H) levels
One crucial parameter in the regulation of flux through
intermediary carbohydrate metabolism, notably at steps in the 3C
stage of glycolysis (the pyruvate-to-lactate conversion) or in further
breakdown via the TCA pathway in mitochondria, is the NAD+/
NADH redox ratio and the absolute intracellular concentration of
these Pyrimidine Nucleotides (PNs). Redox ratio and absolute
concentration of the other main PN pair in mammalian cells, NADP+
and NADPH, is also an important but independent reporter of
metabolic state, and – amongst others – an indicator of a cell’s capacity
to cope with oxidative stress [42].
Figure 4: Cellular NAD(H) and NADP(H) levels. A, Pyrimidine
nucleotide concentrations, expressed as pmoles per 106 cells, were
determined as described in Venter et al. [31]. Note that cell volume
differs between RAW 264.7 and Maf-DKO cells (see text). Bars
represent the mean ± SEM of all control values measured in three
separate experiments (n = 12). B, NAD+/NADH and NADPH/
NADP+ ratios were calculated for every sample individually, using
the control values referred to above (n = 12).
Direct comparison of total NAD+, NADH, NADP+ and NADPH
concentrations measured in pools of 1 x 106 RAW 264.7 and Maf-
DKO cells each, revealed steady-state concentrations of 219.31 ± 17.81
pmol vs. 989.91 ± 85.63 pmol for NAD+, 57.85 ± 5.99 pmol vs. 183.60
± 27.11 pmol for NADH, 23.23 ± 3.65 pmol vs. 141.84 ± 19.07 pmol
for NADP+, and 258.61 ± 11.83 pmol vs. 283.50 ± 31.79 pmol for
NADPH, respectively (Figure 4A). From cell shape and size differences
between RAW 264.7 and Maf-DKO cells (see Figure 5 and data not
shown) we estimate that Maf-DKO cells have an approximately 3-fold
larger volume. Hence, we conclude that the absolute concentrations of
the NAD+ and NADH do not differ conspicuously between the two
cell types.
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Figure 5: Scanning electron microscope images of RAW 264.7 and Maf-DKO cells, cultured in the presence and absence of M-CSF and LPS.
RAW 264.7 cells in normal culture medium (A-D), RAW 264.7 cells in medium containing 20% L929-cell CM (E-H), Maf-DKO cells in
medium containing 20% L929-cell CM (I-L). (Bars = 10 µm)
In keeping with this finding is that both cells express almost similar
and clearly detectable levels of NAMPT, the key and rate limiting
enzyme for salvage synthesis of NAD+ (similar when normalized to
total cellular protein, or 3-fold less in Maf-DKO when normalized to
total tubulin as loading control; see Supplementary Figure S1 and also
Venter et al. [31]).
Interestingly, however, the NADPH/NADP+ redox ratio differed
between cell types and appeared in RAW 264.7 cells 4-fold higher than
in Maf-DKO cells (Figure 4B). This finding may be explained by
assuming that RAW 264.7 cells have to cope with a higher level of
oxidative stress, a common feature found in cells that have undergone
malignant transformation [43,44]. Also other genome differences,
including the effects of MafB/c-Maf absence in Maf-DKO cells or
oncogenic changes in the RAW 264.7 genome may have played a role.
A more detailed characterization of NAD+-related metabolism and its
coupling to macrophage immune function can be found in Venter et
al. [31].
When taken together, our descriptive characterization data reveal
that the signatures of carbohydrate metabolism do not overly differ
between RAW 264.7 and Maf-DKO cells. RAW 264.7 may be
marginally more active in pyruvate-to-lactate conversion, and invest
more heavily in NADPH production (presumably via activation of the
pentose phosphate pathway), but oxygen consumption rate, as a
measure for mitochondrial pathway activity, was at a similar low level
for both cell types.
Morphodynamic properties of RAW 264.7 and Maf-DKO
cells
In various other studies an inverse reciprocal relationship between
proliferation capacity and morphological and functional specialization
upon polarization has been demonstrated [45]. Also a tight coupling
between intermediary metabolism and morphodynamic activity has
been well established [31,42,46-48]. In view of these different types of
coupling, and because no conspicuous differences in metabolic profiles
were found between RAW 264.7 and Maf-DKO cells, we next asked
whether our findings would also predict similarities in
morphodynamic phenotype.
To answer this question we first used scanning electron microscopy
to compare the morphological appearance of RAW 264.7 cells with
that of Maf-DKO cells. As M-CSF induces morphology changes in
macrophages [49], we tested RAW 264.7 cells under medium
conditions with and without L929-cell CM, whereas Maf-DKO was
continuously kept in presence of M-CSF to maintain their
differentiated phenotype.
Both lineages were additionally stimulated overnight with 100
ng/ml LPS before fixation and image acquisition. Strikingly, profound
differences were observed in the growth pattern and morphology of
RAW 264.7 cells in the presence and absence of M-CSF. Without M-
CSF, RAW 264.7 cells grew in a clump-wise fashion and had a
rounded shape (Figures 5A and 5B), while the addition of M-CSF
induced the formation of cellular protrusions and caused the cells to
arrange themselves more loosely, similar to Maf-DKO cells (Figures
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5E and 5F). Interestingly, Maf-DKO cells displayed a more complex
surface morphology compared to RAW 264.7. Maf-DKO cell surfaces
were densely decorated with protrusive membrane structures, which
we henceforth designate as membrane ruffles throughout this piece
(Figures 5I and 5J). RAW 264.7 cell surfaces were more ‘bald’,
displaying only few ruffles (Supplementary Figure S2). LPS induces an
inflammatory phenotype in macrophages that is accompanied by
morphological change [50,51]. Under our culture conditions cell
spreading was prominently induced by LPS in RAW 264.7 both in the
absence and presence of M-CSF (Figures 5C, 5D, 5G and 5H), as well
as in Maf-DKO cells (Figures 5K and 5L).
To us, the relative high abundance of ruffle-like structures on Maf-
DKO cells suggests that these cells have a dynamically more active
cortical actin cytoskeleton than RAW 264.7 cells. This feature could
help them to effectively probe their environment. Possibly, under the
conditions used, a high percentage of the “cell-dorsal” surface
protrusions represent the membrane folds that are actively involved in
the non-selective uptake of molecules, nutrients, and antigens from the
medium through a process called macropinocytosis [9].
Figure 6: Actin cytoskeletal morphology and actin expression in
RAW 264.7 and Maf-DKO cells. Western blot quantification of
actin expression in RAW 264.7 and Maf-DKO cells relative to
tubulin (A). Data represent ratios of actin and tubulin band
intensities of one blot. B-E, Cells were seeded on glass coverslips
and stimulated overnight with LPS (100 ng/ml) or left
unstimulated. After fixation, cells were stained with Alexa568-
labled phaloidin and imaged on a Zeiss LSM510 META confocal
laser scanning microscope.
Our results thus suggest that Maf-DKO cells may be much more
active in this uptake than RAW 264.7. Indeed, this interpretation
would be consistent with the findings of Aziz et al. [52], who observed
that the actin organization of MafB-deficient macrophages is altered
and that a number of proteins involved in actin polymerization, as well
as actin itself, were upregulated compared to control cells, thereby
suggesting a role for MAFB in the regulation of actin dynamics.
Indeed, two pieces of evidence corroborate this picture here, and
suggest a differential role for actin in Maf-DKO and RAW 264.7 cells.
Firstly, when normalized to tubulin expression, we found that Maf-
DKO cells expressed considerably more actin than RAW 264.7 cells
(Figure 6A). Secondly, staining with phalloidin revealed that RAW
264.7 and Maf-DKO cells have a noticeably different morphology of
the actin cytoskeleton (Figures 6B and 6C). In RAW 264.7 cells,
prominent actin-rich filopodial structures could be distinguished,
while Maf-DKO cells displayed a more ‘cloudy’ actin staining. This
‘cloudy’ staining could be the result of the dense organization of
membrane sheets and ruffles on the surface of Maf-DKO cells, making
it difficult to distinguish separate structures. In the presence of LPS,
Maf-DKO cells also developed actin rich filopodia, but these structures
were still more prominent in RAW 264.7 cells (Figures 6D and 6E).
Next, to verify whether the similarities in metabolic phenotype
indeed combine with differences in actin-based morphodynamic
behavior, and that not just a picture of false dichotomy is created for
the two macrophage lineages on the basis of differences in static
appearance, we decided to measure phagocytosis efficiency as a
quantitative measure of mophodynamic activity. To this end, we
determined uptake efficiency of Complement Opsonized Zymosan
(COZ) in the presence and absence of LPS and M-CSF. As shown in
Figure 7A, RAW 264.7 phagocytosis was low in the absence of LPS and
M-CSF (-LPS). In the presence of LPS, the ability to engulf COZ was
markedly improved, while the addition of M-CSF reduced the RAW
264.7 phagocytosis efficiency. Aziz, et al. [27] reported that, compared
to primary wild type macrophages, the phagocytic activity of Maf-
DKO cells is not altered. We found here that, compared to RAW 264.7
cells, they exhibited significantly greater phagocytosis efficiency, even
in the absence of LPS or M-CSF (Figure 7A). Pre-stimulation with LPS
did not affect COZ engulfment by Maf-DKO cells, while M-CSF
increased the phagocytosis efficiency significantly. The two cell lines,
therefore, clearly have a differential dependency on M-CSF for
phagocytosis. Most literature studies report on a stimulatory effect of
M-CSF on phagocytosis [53,54] in agreement with our observation for
the Maf-DKO cells, although an inhibitory effect of M-CSF on
phagocytosis of serum opsonized yeast cells in resident peritoneal
macrophages is mentioned in one study [49]. Currently it is unclear
how M-CSF can have such differential effects on phagocytosis in
different macrophage cells. Although truly opposing effects are
difficult to explain, it is possible that activity of the receptor for M-CSF
(CSF-1R) or downstream pathways in M-CSF-induced signalling are
differentially controlled in macrophages of different origin. Our
observation that RAW 264.7 cells required LPS induction to activate
phagocytic capacity, while Maf-DKO cells were far more efficient in
phagocytosis of COZ particles even in the absence of any additional
external stimulus strengthen this possibility. Another explanation may
be that the difference is not in signalling pathways but that (as we
show in Figures 5A and 5I) Maf-DKO cells are structurally better
equipped to capture phagocytic targets than RAW 264.7 cells, because
their surface is permanently more abundantly decorated with
membrane sheets and ruffles, structures that have been shown to be
involved in the capturing of complement opsonized particles [55].
Upon stimulation with LPS, membrane ruffle formation is induced
(Figure 5C and 5D), along with the activation of the complement
receptor [56], explaining why phagocytosis is improved with LPS in
RAW 264.7 cells.
Finally, we analyzed whether metabolic modulation would affect
morphodynamic capacity differentially, to explain the obvious
qualitative and quantitative phenotypic differences between both
macrophage lineages. For this, rather short-term analyses, using
conditions with 3 hr or 24 hr inhibition with 2-deoxy-D-glucose (2-
DG) or oligomycin, respectively, were chosen to avoid metabolic
adaptation, or effects on growth or other aspects of cell viability
(Figure 1). Interestingly, our tests revealed that phagocytic COZ-
uptake capacity by RAW 264.7 and Maf-DKO cells decreased similarly
strong when glycolysis was impaired, but that blocking of
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mitochondrial oxidative phosphorylation activity [46] had no effect on
both cell lines (Figures 7B and 7C).
Figure 7: Phagocytosis of COZ in RAW 264.7 and Maf-DKO cells
in the presence and absence of M-CSF, LPS, or metabolic
inhibitors. A, Phagocytic index of RAW 264.7 and Maf-DKO cells
was determined with or without LPS (±LPS) and with or without
L929-cell CM (± M-CSF). All bars were normalized to the RAW
264.7+LPS bar. Data represent means ± SEM of three independent
experiments performed in triplo. (*p<0.05, **p<0.01, ***p<0.001,
two-way ANOVA and Bonferroni posttest). Phagocytosis capacity
in the presence of OXPHOS inhibitor oligomycin (2.5 µM) (B), or
glycolysis inhibitor 2-DG (10 mM) (C). Inhibitors were
administered for the time periods indicated. Analysis of data was as
given in Venter et al. [46]. Figures represent normalized means
±SEM of three independent experiments performed in triplicate.
(*p<0.05, **p<0.01, ***p<0.001; one-sample t-test). Note the
fluctuations in phagocytic index in RAW 264.7 cells, caused by
oligomycin administration. At 24 hour oligomycin inhibition
consistently produced even a stimulatory effect. We attribute these
variations to metabolic adaptation to medium replenishment, for
which the RAW 264.7 lineage appears highly sensitive
Phagocytic activity is a process which involves the coordination of
multiple actin-based events with sudden and high energy demand. To
us, our observations suggest that, although they display a marked
difference in phagocytic potential, RAW 264.7 and Maf-DKO
macrophages coordinate this entire process similarly in that they
uniquely use fuelling by glycolysis.
In summary: Here, we have compared gross features of
carbohydrate metabolism, proliferative capacity, and
morphofunctional properties of Maf-DKO and RAW 264.7
macrophages, two macrophage cell lines that have an entirely different
origin and history, and differentiation potential. Although there is
ample evidence in literature for the existence of tight links between
cellular metabolism, proliferative capacity and morphodynamic
activity, we observed that both cell types share a common identity in
intermediary metabolism while their behavioral properties diverge
widely. While the expression levels of glycolytic enzymes and the rates
of lactate production and oxygen consumption were largely similar the
two cell lines exhibited vastly different proliferation rates, with the
RAW 264.7 lineage having a markedly shorter doubling time,
consistent with its tumorigenic origin. Maf-DKO cells, on the other
hand, were morphodynamically much more active, displaying a
strikingly more complex cell surface morphology and significantly
greater phagocytosis efficiency. This apparent dichotomy may be best
explained by assuming that, although the global rate of glycolysis in
intermediary carbohydrate metabolism is similar for both cell lineages,
there is differential use for this pathway. In Maf-DKO cells, its main
role could be as supply pathway for ATP or metabolic intermediates to
deliver fuel or cell constituents (e.g. lipids) for morphodynamic
activity. In RAW 264.7 cells (aerobic) glycolysis may predominantly
serve as supply pathway for associated metabolic routes for the
production of precursors (nucleotides, proteins, lipids) in generation
of cell biomass, or for redox protection (NADPH synthesis in the PP
Pathway).
Epstein, et al. [57] have proposed that glycolysis and oxidative
phosphorylation are complementary production modes that supply
ATP to different cellular processes with different timescales of energy
demands. In their model, cells exploit the efficiency of aerobic
metabolism to meet baseline, steady-energy demand, and the rapid
response time of glycolysis to meet short-timescale energy demands.
By extrapolating our observations, based on the use of only two
macrophage lineages of entirely different origin, we propose that the
overall glycolytic phenotype might provide macrophages, irrespective
of origin and specialization, with sufficient metabolic versatility and
flexibility to meet with the demands that are required to fuel their
vastly different immune functions. More study is necessary to better
understand all details of how different aspects of carbohydrate, energy
and redox metabolism are fine-tuned in accordance with growth and
immune function before and after polarization and specialization of
these highly plastic cell types. Clearly, also further comparative
analyses are needed, but – based on our findings - we consider Maf-
DKO cells that exhibit many of the typical properties of primary wild
type macrophages [27], a well suited intermediate model for such
studies.
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